GLUL

STAINING OVERVIEW

? »

Overall cancer tissue 
staining statistics


0%
25%
50%
75%
100%

Tissue presentation order

Histological

Alphabetical

 

Antibody HPA007316

Antibody HPA007571

Antibody CAB008636

Tissue

Antibody staining

Antibody staining

Antibody staining

Colorectal cancer
Breast cancer
Prostate cancer
Ovarian cancer
Cervical cancer
Endometrial cancer
Carcinoid
Head and neck cancer
Thyroid cancer
Glioma
Lymphoma
Lung cancer
Melanoma
Skin cancer
Testis cancer
Urothelial cancer
Renal cancer
Stomach cancer
Pancreatic cancer
Liver cancer

Summary

Moderate to strong staining was observed in most malignant gliomas, breast, liver and colorectal cancers as well as cases of cervical, ovarian and urothelial cancers. Remaining malignancies were in general negative.Malignant cells were mainly negative. Hepatocellular carcinomas showed strong staining while breast, urothelial and prostate cancers displayed some moderately positive cases.Most malignant cells showed moderate cytoplasmic positivity. Strong staining was observed in malignant gliomas, colorectal and liver cancers. Skin cancers were weakly stained or negative.

Literature conformity

Partly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization dataPartly consistent with extensive gene/protein characterization data

Level of antibody staining/expression





High
Medium
Low
Not detected